chartexchange

TOVX
Theriva Biologics, Inc.
stockNYSEAMERICAN

At CloseNov 18, 2026 3:43:45 PM EST
0.15USD+3.929%(+0.01)550,843
Pre-marketNov 18, 2026 8:50:30 AM EST
0.1421USD+1.500%(+0.0021)
After-hoursNov 18, 2026 4:55:30 PM EST
0.1406USD-3.368%(-0.0049)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Rockville, MD, USA
Previous Close
$0.14
Beta
2.50
52-Week High
$0.49 2026-04-20
52-Week Low
$0.14 2026-11-05
SMA 50
$0.20
SMA 200
$0.24
Avg. Vol 10D
704,068
Avg. Vol 30D
3.71M
Avg. Vol 90D
1.58M
Relative Vol
0.15
45.14M
3.7600%
2,700,000
93,707
Aug 26, 2024 · 1-for-25 (reverse)
Nov 12, 2026
TOVX Profile

synthetic biologics, inc. (nyse mkt: syn) is a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and restore the health of patients. the company's lead candidates poised for phase 3 development are: (1) syn-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (ibs-c), and (2) syn-004 (ribaxamase) which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (iv) beta-lactam antibiotics for the prevention of c. difficile infection (cdi), antibiotic-associated diarrhea (aad) and the emergence of antimicrobial-resistance (amr). the company is also developing preclinical stage monoclonal antibody therapies for the prevention and treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria (pku).

TOVX Performance
PeriodPriceDateChangeBeta
1W0.162026-11-12-6.88%-0.446
1M0.202026-10-19-27.21%1.877
3M0.232026-08-19-33.90%1.714
6M0.272026-05-19-44.17%1.853
1Y0.232025-11-19-35.30%2.502
2Y1.262024-11-19-88.17%—
5Y25.762022-10-13-99.42%0.927
TOVX Stock Summary

Theriva Biologics, Inc. (NYSEAMERICAN:TOVX) stock price today is $0.15, and today's volume is 550,843. TOVX is up 6.429% today. The 30 day average volume is 3.71M. TOVX market cap is $6.84M with 45.89M shares outstanding.